Skip to main content

MDNAF · Medicenna Therapeutics Corp. · Analyst Estimates

Track MDNAF — free
$0.31 +0.03 (+9.40%) At close · Sep 18
Market Cap
$27.41M
Shares
92.30M

Analyst Estimates

Compare analyst forecasts for Medicenna Therapeutics Corp. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 13:00 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2027-03-31

Analyst estimates for FY ending 2027-03-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.159
-0.1555
-0.152
-0.2395
-0.26575
-0.2395
-0.26575
EPS
analysts
Publication date not stated
2
0
0
2
2
Revenue
CAD
Publication date not stated
0
0
0
Revenue
analysts
Publication date not stated
3

FY ending 2028-03-31

Analyst estimates for FY ending 2028-03-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.793
-0.356
-0.13
-0.335
-0.35967
-0.335
-0.35967
EPS
analysts
Publication date not stated
3
0
0
1
1
Revenue
CAD
Publication date not stated
0
1250000
3750000
Revenue
analysts
Publication date not stated
3

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.036
-0.036
-0.036
-0.042
-0.051
-0.042
-0.051
EPS
analysts
Publication date not stated
2
0
0
2
2
Revenue
CAD
Publication date not stated
0
0
0
Revenue
analysts
Publication date not stated
3

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.043
-0.0395
-0.036
-0.042
-0.059
-0.042
-0.059
EPS
analysts
Publication date not stated
2
1
1
1
1
Revenue
CAD
Publication date not stated
0
0
0
Revenue
analysts
Publication date not stated
3
Key facts CIK 1807983 CUSIP 58490H107 Visit website Investor relations